Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Candesartan Cilexetil
Drug class: Angiotensin II receptor blockers (ARBs), plain
Group: ACE inhibitors and sartans
Route: Oral
Dosage form: Tablet
Applicant: Zydus Lifesciences
Status: Prescription
FDA approval: 23 Aug 2017
Application: ANDA091390-002
RxCUI: 135481

Guidelines

FDA 2024

Entresto Sprinklesacubitril · Capsule, pellets

Filsparisparsentan · Tablet

ValsartanSolution

Olmesartan MedoxomilTablet

Olmesartan Medoxomil and Hydrochlorothiazidehydrochlorothiazide · Tablet

Byvalsonnebivolol hydrochloride · Tablet

Entrestosacubitril · Tablet

Telmisartan and Hydrochlorothiazidehydrochlorothiazide · Tablet

TelmisartanTablet

Telmisartan and Amlodipineamlodipine besylate · Tablet

Epaned Kitenalapril maleate · For solution

Amlodipine Besylate and Valsartanamlodipine besylate · Tablet

Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil · Tablet

Irbesartan; Hydrochlorothiazideirbesartan: hydrochlorothiazide · Tablet

Amlodipine Besylate, Valsartan and Hydrochlorothiazideamlodipine besylate · Tablet

Valsartan and Hydrochlorothiazidehydrochlorothiazide · Tablet